Data Composite

Recall D-0657-2026

US Class II Ongoing · initiated 2026-06-12

Recalling firm

Boehringer Ingelheim Pharmaceuticals, Inc., CT

Product

Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45

Reason for recall

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

← All recalls